Fig. 16From: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluationAntioxidant enzyme (MDA, GSH, SOD, and CAT) levels were quantified at the end of the protocol in the PC group as compared to pure VC and NFs of VC-loaded TCs-HA treatment groups (n = 10, mean ± SD, p ≤ 0.05)Back to article page